Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways

K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Y Tan, Z Zhang, C Zheng, KA Wintergerst… - Nature Reviews …, 2020 - nature.com
The pathogenesis and clinical features of diabetic cardiomyopathy have been well-studied
in the past decade, but effective approaches to prevent and treat this disease are limited …

Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy

K Watanabe, RA Thandavarayan… - Current cardiology …, 2010 - ingentaconnect.com
Diabetes mellitus increases the risk of heart failure independently of underlying coronary
artery disease, and many believe that diabetes leads to cardiomyopathy. The underlying …

Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy

NJ Byrne, NS Rajasekaran, ED Abel… - Free Radical Biology and …, 2021 - Elsevier
Even in the absence of coronary artery disease and hypertension, diabetes mellitus (DM)
may increase the risk for heart failure development. This risk evolves from functional and …

Role of oxidative stress in diabetic cardiomyopathy

B De Geest, M Mishra - Antioxidants, 2022 - mdpi.com
Type 2 diabetes is a redox disease. Oxidative stress and chronic inflammation induce a
switch of metabolic homeostatic set points, leading to glucose intolerance. Several diabetes …

Oxidative stress and diabetic cardiomyopathy: a brief review

LU Cai, YJ Kang - Cardiovascular toxicology, 2001 - Springer
Diabetes is a serious public health problem. Improvements in the treatment of noncardiac
complications from diabetes have resulted in heart disease becoming a leading cause of …

Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?

X Palomer, J Pizarro-Delgado… - Trends in pharmacological …, 2018 - cell.com
The diabetic heart is characterized by metabolic disturbances that are often accompanied by
local inflammation, oxidative stress, myocardial fibrosis, and cardiomyocyte apoptosis …

Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting

AJ Wilson, EK Gill, RA Abudalo, KS Edgar, CJ Watson… - Heart, 2018 - heart.bmj.com
Despite being first described 45 years ago, the existence of a distinct diabetic
cardiomyopathy remains controversial. Nonetheless, it is widely accepted that the diabetic …

Signaling pathways related to oxidative stress in diabetic cardiomyopathy

M Peng, Y Fu, C Wu, Y Zhang, H Ren… - Frontiers in …, 2022 - frontiersin.org
Diabetes is a chronic metabolic disease that is increasing in prevalence and causes many
complications. Diabetic cardiomyopathy (DCM) is a complication of diabetes that is …

Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity

G Jia, MA Hill, JR Sowers - Circulation research, 2018 - Am Heart Assoc
Heart failure and related morbidity and mortality are increasing at an alarming rate, in large
part, because of increases in aging, obesity, and diabetes mellitus. The clinical outcomes …